by Manish M Patel, Maritza Patzi, Desiree Pastor et al.
BMJ 2013;346:f3726 (Published 19 June 2013)
11 pp. 430 kB:
The objective of the study was to evaluate the effectiveness of two doses of a monovalent rotavirus vaccine (RV1) against hospital admission for rotavirus in Bolivia. The authors conclude that the vaccine conferred high protection against hospital admission for diarrhoea due to rotavirus in Bolivian children. Protection was sustained through two years of life against diverse serotypes different from the vaccine strain.